
News|Articles|December 1, 2001
Viread (Tenofovir disoproxil fumarate tablets) Gilead
NMEs/biologics:First nucleotide analog for treatment of HIV-1 infection; dosed once daily
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves brepocitinib for rare skin disease
2
Medicare Advantage enrollees more likely to leave after new complex diagnosis
3
USPS Woes Continue: Health Plans, Be Prepared
4
FDA approves Gilead’s Bixlenvo, smallest single-tablet option for virologically suppressed HIV patients
5
























